心脏术后早期冠状动脉造影或血运重建的结局
该回顾性观察研究基于1996-2017年单中心53,287例心脏手术患者,其中180例(0.34%)在术后3周内因疑似冠脉缺血行冠状动脉造影±经皮冠状动脉介入或再次冠状动脉旁路移植术。主要结局为1年全因死亡率。
要点
- 心脏术后早期疑似冠脉缺血需造影或干预者虽罕见(0.34%),但1年死亡率高。
- STEMI/NSTEMI患者1年死亡率最低(13.5%),非室速/室颤性心脏骤停或仅血流动力学不稳定者最差(38.6%)。
- 术后肌钙蛋白T峰值可预测1年死亡率(AUC 0.74),但不能预测冠状动脉或移植血管阻塞。
核心结论
- 心脏术后早期疑似心肌缺血需冠状动脉造影或干预虽罕见,但死亡率高,尤其非STEMI/NSTEMI表现者。
- 术后肌钙蛋白T不是潜在冠状动脉或移植血管阻塞的可靠标志物,但能强预测1年死亡率。
研究设计与样本
- 回顾性观察研究,基于单中心1996-2017年53,287例心脏手术患者数据。
- 180例(0.34%)符合纳入标准,在术后3周内因疑似冠脉缺血行冠状动脉造影±经皮冠状动脉介入或再次冠状动脉旁路移植术。
主要发现
- 多数冠状动脉造影±经皮冠状动脉介入和再次冠状动脉旁路移植术在术后前2周内进行。
- 急性移植血管失败时,经皮冠状动脉介入的1年死亡率(18.2%)优于再次冠状动脉旁路移植术(23.5%)或无指征/可行干预(29.2%)。
临床怎么用
- 心脏术后出现明确心肌缺血症状和体征时,应警惕早期冠状动脉或移植血管阻塞,及时评估。
- 肌钙蛋白T升高不能单独用于判断冠状动脉或移植血管阻塞,但可用于风险分层预测1年死亡。
局限性
- 回顾性观察研究,仅基于单中心数据,可能存在选择偏倚。
- 符合纳入标准的患者仅180例(0.34%),样本量小,统计效能有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Early coronary ischemic events are uncommon after cardiac surgery, with little known about their management or associated outcomes. We evaluated clinical outcomes of patients undergoing coronary angiography ± percutaneous coronary intervention or redo coronary artery bypass grafting for suspected coronary ischemia within 3 weeks after index cardiac surgery. METHODS: This is a retrospective observational study based on data from 53,287 patients who underwent cardiac surgery at our institution (1996-2017); 180 patients (0.34%) satisfied the inclusion criteria. The primary outcome was 1-year all-cause mortality. Statistical evaluation involved χ2, analysis of variance, Kaplan-Meier, and receiver operating characteristic curve analyses. RESULTS: Most coronary angiography ± percutaneous coronary intervention and redo coronary artery bypass grafting procedures occurred in the first 2 weeks after index cardiac surgery. Patients presenting with ST elevation myocardial infarction (STEMI)/non-STEMI had the lowest 1-year mortality (13.5%), followed by patients with ventricular tachycardia/fibrillation (28.1%), and patients with non-ventricular tachycardia/fibrillation arrest or hemodynamic instability alone the worst (38.6%) (χ2 = 17.3, P = .001). Peak troponin T level after cardiac surgery was strongly predictive of 1-year mortality (area under the curve, 0.74; 95% confidence interval, 0.65-0.84; P < .001) but did not predict the presence of coronary compromise. For acute graft failure, 1-year mortality was better with percutaneous coronary intervention (18.2%) than redo coronary artery bypass grafting (23.5%) or no indicated/feasible intervention (29.2%). CONCLUSIONS: Although suspected myocardial ischemia requiring coronary angiography or intervention early after cardiac surgery was rare, mortality was high, particularly in presentations other than STEMI/non-STEMI. In patients with overt signs and symptoms of myocardial ischemia after index cardiac surgery, troponin T was not a reliable marker of underlying coronary or graft obstruction but was a robust predictor of 1-year mortality.
引用
- Sharma V, Chen K, Alansari SAR, et al. Outcomes of Early Coronary Angiography or Revascularization After Cardiac Surgery. Ann Thorac Surg. 2020. PMID: 32946843. doi:10.1016/j.athoracsur.2020.06.113
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。